Ost-müük SAB Biotherapeutics, Inc. - SABS CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.07 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 0.87 |
Avatud* | 0.87 |
Aastane muutus* | -54.21% |
Päeva ulatus* | 0.85 - 0.89 |
52 nädala ulatus | 0.37-2.19 |
Keskmine maht (10 päeva) | 83.11K |
Keskmine maht (3 kuud) | 28.48M |
Turukapitalisatsioon | 45.61M |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 50.40M |
Tulu | 12.68M |
EPS | -0.60 |
Dividendid (% kasumist) | N/A |
Beeta | -100.00K |
Järgmine tuluaruande kuupäev | Aug 8, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
May 31, 2023 | 0.85 | 0.02 | 2.41% | 0.83 | 0.88 | 0.83 |
May 30, 2023 | 0.87 | 0.05 | 6.10% | 0.82 | 0.88 | 0.82 |
May 26, 2023 | 0.84 | 0.01 | 1.20% | 0.83 | 0.86 | 0.82 |
May 25, 2023 | 0.82 | -0.04 | -4.65% | 0.86 | 0.86 | 0.82 |
May 24, 2023 | 0.87 | 0.04 | 4.82% | 0.83 | 0.87 | 0.83 |
May 23, 2023 | 0.84 | -0.02 | -2.33% | 0.86 | 0.87 | 0.81 |
May 22, 2023 | 0.87 | 0.06 | 7.41% | 0.81 | 0.90 | 0.80 |
May 19, 2023 | 0.79 | -0.03 | -3.66% | 0.82 | 0.83 | 0.79 |
May 18, 2023 | 0.83 | 0.03 | 3.75% | 0.80 | 0.85 | 0.80 |
May 17, 2023 | 0.82 | 0.05 | 6.49% | 0.77 | 0.83 | 0.77 |
May 16, 2023 | 0.75 | -0.08 | -9.64% | 0.83 | 0.83 | 0.73 |
May 15, 2023 | 0.85 | -0.01 | -1.16% | 0.86 | 0.90 | 0.84 |
May 12, 2023 | 0.90 | -0.03 | -3.23% | 0.93 | 0.95 | 0.85 |
May 11, 2023 | 0.90 | -0.02 | -2.17% | 0.92 | 0.94 | 0.89 |
May 10, 2023 | 0.93 | 0.05 | 5.68% | 0.88 | 0.93 | 0.88 |
May 9, 2023 | 0.89 | -0.01 | -1.11% | 0.90 | 0.95 | 0.86 |
May 8, 2023 | 0.94 | 0.10 | 11.90% | 0.84 | 0.97 | 0.82 |
May 5, 2023 | 0.84 | 0.03 | 3.70% | 0.81 | 0.86 | 0.79 |
May 4, 2023 | 0.87 | -0.08 | -8.42% | 0.95 | 1.16 | 0.80 |
May 3, 2023 | 0.85 | 0.07 | 8.97% | 0.78 | 0.85 | 0.78 |
SAB Biotherapeutics, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
Wednesday, June 14, 2023 | ||
Kellaaeg (UTC) (UTC) 18:30 | Riik US
| Sündmus SAB Biotherapeutics Inc R&D Day SAB Biotherapeutics Inc R&D DayForecast -Previous - |
Thursday, July 6, 2023 | ||
Kellaaeg (UTC) (UTC) 14:00 | Riik US
| Sündmus SAB Biotherapeutics Inc Annual Shareholders Meeting SAB Biotherapeutics Inc Annual Shareholders MeetingForecast -Previous - |
Tuesday, August 8, 2023 | ||
Kellaaeg (UTC) (UTC) 12:30 | Riik US
| Sündmus Q2 2023 SAB Biotherapeutics Inc Earnings Release Q2 2023 SAB Biotherapeutics Inc Earnings ReleaseForecast -Previous - |
Monday, November 13, 2023 | ||
Kellaaeg (UTC) (UTC) 13:30 | Riik US
| Sündmus Q3 2023 SAB Biotherapeutics Inc Earnings Release Q3 2023 SAB Biotherapeutics Inc Earnings ReleaseForecast -Previous - |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | |
---|---|---|---|
Kogutulu | 23.9042 | 60.8761 | 55.2378 |
Tulu | 23.9042 | 60.8761 | 55.2378 |
Kogu tegevuskulu | 52.8218 | 73.6037 | 34.681 |
Müük/Üldine/admin kulud, kokku | 16.3833 | 17.0857 | 6.7723 |
Uuringud ja arendus | 36.0325 | 57.1836 | 27.9087 |
Ootamatud kulutused (tulu) | 0 | -0.6656 | 0 |
Tulud majandustegevusest | -28.9176 | -12.7276 | 20.5568 |
Intressitulud (kulu), muud tulud, neto | 10.1687 | -4.42241 | -0.44302 |
Muud, neto | 0.03375 | 0.00549 | 0.004 |
Netotulu enne makse | -18.7152 | -17.1445 | 20.1178 |
Netotulu pärast makse | -18.7408 | -17.1445 | 20.1178 |
Netotulu enne erikulusid | -18.7408 | -17.1445 | 20.1178 |
Netotulu | -18.7408 | -17.1445 | 20.1178 |
Arvestatav tulu, v a erikulud | -18.7408 | -17.1445 | 20.1178 |
Arvestatav tulu, koos erikuludega | -18.7408 | -17.1445 | 20.1178 |
Jaotamisele kuuluv netotulu | -18.7408 | -17.1445 | 20.1178 |
Keskmine jaotamisele kuuluv aktsia kohta | 43.525 | 42.9551 | 27.0115 |
Jaotatav EPS, v a erakorralised kulud | -0.43058 | -0.39913 | 0.74479 |
Dividends per Share - Common Stock Primary Issue | 0 | ||
Jaotamisele kuuluv normaal-EPS | -0.43058 | -0.41462 | 0.74479 |
Depreciation / Amortization | 0.284 | ||
Intressikulu (tulu) - neto majandustegevusest | 0.122 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kogutulu | 0.5811 | 2.16087 | 3.58971 | 18.1536 | 11.8031 |
Kogu tegevuskulu | 7.98311 | 10.0209 | 11.397 | 31.4039 | 18.5104 |
Other Operating Expenses, Total | -0.092 | ||||
Tulud majandustegevusest | -7.40201 | -7.86001 | -7.80731 | -13.2503 | -6.70734 |
Intressitulud (kulu), muud tulud, neto | 0.04818 | -0.02118 | 0.72972 | 9.46015 | 7.78549 |
Muud, neto | 0.03223 | 0.00153 | 0 | ||
Netotulu enne makse | -7.35382 | -7.84897 | -7.07607 | -3.79014 | 1.07814 |
Netotulu pärast makse | -7.35382 | -7.8746 | -7.07607 | -3.79014 | 0.98586 |
Netotulu enne erikulusid | -7.35382 | -7.8746 | -7.07607 | -3.79014 | 0.98586 |
Netotulu | -7.35382 | -7.8746 | -7.07607 | -3.79014 | 0.98586 |
Arvestatav tulu, v a erikulud | -7.35382 | -7.8746 | -7.07607 | -3.79014 | 0.98586 |
Arvestatav tulu, koos erikuludega | -7.35382 | -7.8746 | -7.07607 | -3.79014 | 0.98586 |
Jaotamisele kuuluv netotulu | -7.35382 | -7.8746 | -7.07607 | -3.79014 | 0.98586 |
Keskmine jaotamisele kuuluv aktsia kohta | 50.397 | 44.9728 | 43.0309 | 43.0366 | 43.1133 |
Jaotatav EPS, v a erakorralised kulud | -0.14592 | -0.1751 | -0.16444 | -0.08807 | 0.02287 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.14592 | -0.1751 | -0.16444 | -0.08807 | 0.02287 |
Tulu | 0.5811 | 2.16087 | 3.58971 | 18.1536 | 11.8031 |
Müük/Üldine/admin kulud, kokku | 3.44739 | 2.88277 | 4.04405 | 9.45647 | 5.18607 |
Uuringud ja arendus | 4.44172 | 7.04411 | 7.25698 | 21.7314 | 13.2113 |
Ootamatud kulutused (tulu) | 0 | 0 | 0 | 0 | |
Depreciation / Amortization | 0.025 | 0.186 | 0.025 | 0.073 | 0.041 |
Intressikulu (tulu) - neto majandustegevusest | 0.069 | 0.071 | 0.143 | 0.072 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | |
---|---|---|---|
Käibevarad kokku | 22.0975 | 50.192 | 34.455 |
Raha ja lühiajalised investeeringud | 15.0469 | 33.2067 | 12.6104 |
Raha ja ekvivalendid | 15.0469 | 33.2067 | 12.6104 |
Laekumata arved, neto | 5.55658 | 8.01071 | 20.5695 |
Accounts Receivable - Trade, Net | 5.55658 | 8.01071 | 20.5695 |
Prepaid Expenses | 1.49398 | 2.63622 | 1.27513 |
Other Current Assets, Total | 0 | 6.33831 | 0 |
Total Assets | 50.9049 | 81.1409 | 56.5379 |
Property/Plant/Equipment, Total - Net | 28.3398 | 30.949 | 22.0829 |
Property/Plant/Equipment, Total - Gross | 34.6183 | 34.169 | 23.8501 |
Accumulated Depreciation, Total | -6.27852 | -3.22002 | -1.76719 |
Total Current Liabilities | 14.9933 | 26.4553 | 11.0617 |
Accounts Payable | 3.67912 | 4.45853 | 7.38236 |
Accrued Expenses | 10.3588 | 13.382 | 2.82914 |
Notes Payable/Short Term Debt | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.90545 | 1.95777 | 0.73345 |
Other Current Liabilities, Total | 0.05 | 6.65692 | 0.11678 |
Total Liabilities | 19.8468 | 42.591 | 17.5301 |
Total Long Term Debt | 4.17129 | 3.76243 | 4.09559 |
Long Term Debt | 0.54164 | 0 | 0.17204 |
Capital Lease Obligations | 3.62964 | 3.76243 | 3.92355 |
Other Liabilities, Total | 0.68216 | 12.3733 | 2.37278 |
Total Equity | 31.0581 | 38.5499 | 39.0078 |
Common Stock | 0.00509 | 0.00435 | 0.0026 |
Additional Paid-In Capital | 84.4441 | 67.6745 | 50.9897 |
Retained Earnings (Accumulated Deficit) | -47.8698 | -29.129 | -11.9844 |
Total Liabilities & Shareholders’ Equity | 50.9049 | 81.1409 | 56.5379 |
Total Common Shares Outstanding | 50.3943 | 43.4873 | 25.9734 |
Other Long Term Assets, Total | 0.46769 | 0 | |
Treasury Stock - Common | -5.52125 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 15.032 | 22.0975 | 22.1821 | 27.7505 | 36.1697 |
Raha ja lühiajalised investeeringud | 13.0601 | 15.0469 | 8.33219 | 16.6165 | 22.4084 |
Cash | |||||
Prepaid Expenses | 1.20878 | 1.49398 | 0.90787 | 1.52138 | 1.97491 |
Total Assets | 42.672 | 50.9049 | 52.5075 | 59.1549 | 67.4725 |
Long Term Investments | |||||
Other Long Term Assets, Total | 0.434 | 0.46769 | 0.50139 | 0.53508 | |
Total Current Liabilities | 13.6657 | 14.9933 | 17.1012 | 16.1372 | 18.2559 |
Accrued Expenses | 8.65427 | 10.3588 | 11.3686 | 10.9954 | 12.9613 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 18.2695 | 19.8468 | 21.8841 | 22.0336 | 26.2142 |
Total Long Term Debt | 4.13777 | 4.17129 | 3.66254 | 3.69483 | 3.72894 |
Other Liabilities, Total | 0.466 | 0.68216 | 1.12029 | 2.2016 | 4.22939 |
Total Equity | 24.4025 | 31.0581 | 30.6234 | 37.1213 | 41.2583 |
Common Stock | 0.00509 | 0.00509 | 0.00436 | 0.00436 | 0.00435 |
Additional Paid-In Capital | 85.1423 | 84.4441 | 76.1355 | 75.5572 | 74.9183 |
Retained Earnings (Accumulated Deficit) | -55.2236 | -47.8698 | -39.9952 | -32.9191 | -28.1431 |
Total Liabilities & Shareholders’ Equity | 42.672 | 50.9049 | 52.5075 | 59.1549 | 67.4725 |
Total Common Shares Outstanding | 50.3978 | 50.3943 | 43.0309 | 43.0309 | 42.9551 |
Raha ja ekvivalendid | 13.0601 | 15.0469 | 8.33219 | 16.6165 | 22.4084 |
Laekumata arved, neto | 0.76312 | 5.55658 | 12.942 | 9.61267 | 11.7864 |
Accounts Receivable - Trade, Net | 0.76312 | 5.55658 | 12.942 | 9.61267 | 11.7864 |
Other Current Assets, Total | 0 | 0 | 0 | 0 | |
Property/Plant/Equipment, Total - Net | 27.206 | 28.3398 | 29.824 | 30.8693 | 31.3027 |
Accounts Payable | 1.44496 | 3.67912 | 5.48428 | 4.94358 | 4.98139 |
Current Port. of LT Debt/Capital Leases | 0.57729 | 0.90545 | 0.1659 | 0.16578 | 0.17091 |
Other Current Liabilities, Total | 2.9892 | 0.05 | 0.0825 | 0.0325 | 0.14228 |
Long Term Debt | 0.54164 | 0.54164 | |||
Capital Lease Obligations | 3.59613 | 3.62964 | 3.66254 | 3.69483 | 3.72894 |
Property/Plant/Equipment, Total - Gross | 34.383 | 34.6183 | 35.2037 | 35.3823 | 35.0665 |
Accumulated Depreciation, Total | -7.17698 | -6.27852 | -5.37971 | -4.51296 | -3.76377 |
Treasury Stock - Common | -5.52125 | -5.52125 | -5.52125 | -5.52125 | -5.52125 |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | |
---|---|---|---|
Netotulu/algväärtus | -18.7408 | -17.1445 | 20.1178 |
Raha majandustegevusest | -23.4595 | 1.98687 | 10.0048 |
Raha majandustegevusest | 3.16943 | 1.48861 | 0.38314 |
Mittelikviidsed varad | -7.65056 | 5.95965 | 1.45821 |
Muutused tööjõus | -0.23758 | 11.6831 | -11.9543 |
Tulu investeeringutelt | -2.09002 | -10.9437 | -12.7227 |
Kapitalikulutused | -2.16641 | -10.9437 | -12.7317 |
Muud rahavood investeeringutelt, kokku | 0.07639 | 0.009 | |
Rahavood investeeringutelt | 1.05141 | 35.8914 | 8.98232 |
Aktsiate emiteerimine (tagasiost), neto | 2.23652 | 34.347 | 10.5618 |
Laenu väljastamine (kustutamine), neto | -1.18511 | 1.54444 | -1.5795 |
Rahaline kogumuutus | -24.4981 | 26.9346 | 6.26441 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -7.35382 | -18.7408 | -10.8662 | -3.79013 | 0.98586 |
Cash From Operating Activities | -1.60572 | -23.4595 | -23.6762 | -15.5026 | -9.53773 |
Non-Cash Items | 0.63844 | -7.65056 | -8.23501 | -8.05345 | -6.92504 |
Changes in Working Capital | 4.21121 | -0.23758 | -6.84564 | -5.04444 | -4.32706 |
Cash From Investing Activities | -0.0213 | -2.09002 | -1.97227 | -1.89377 | -1.28093 |
Other Investing Cash Flow Items, Total | 0 | 0.07639 | 0.07639 | 0.07639 | 0.07639 |
Cash From Financing Activities | -0.35979 | 1.05141 | -5.56433 | -5.53216 | -6.31795 |
Financing Cash Flow Items | |||||
Issuance (Retirement) of Stock, Net | 0.00189 | 2.23652 | -5.44427 | -5.44428 | -5.51342 |
Issuance (Retirement) of Debt, Net | -0.36168 | -1.18511 | -0.12005 | -0.08788 | -0.80453 |
Net Change in Cash | -1.98681 | -24.4981 | -31.2128 | -22.9285 | -17.1366 |
Cash From Operating Activities | 0.89845 | 3.16943 | 2.27062 | 1.38543 | 0.63624 |
Capital Expenditures | -0.0213 | -2.16641 | -2.04866 | -1.97016 | -1.35732 |
Deferred Taxes | 0 | 0.09228 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Sullivan (Eddie Joe) | Individual Investor | 10.3786 | 5230564 | 0 | 2023-05-12 | LOW |
Hamilton (Christine E) | Individual Investor | 9.9074 | 4993090 | 0 | 2023-05-12 | LOW |
Hamilton (Edward D.) | Individual Investor | 6.1675 | 3108270 | 0 | 2023-05-12 | |
First Premier Bank | Bank and Trust | 1.6023 | 807535 | 0 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.3921 | 701584 | 0 | 2023-03-31 | LOW |
Kropotova (Alexandra) | Individual Investor | 1.1409 | 575000 | 275000 | 2023-03-14 | |
Big Cypress Holdings, L.L.C. | Corporation | 1.0868 | 547698 | 0 | 2023-05-12 | |
Veritable, L.P. | Investment Advisor/Hedge Fund | 1.005 | 506513 | 0 | 2023-03-31 | LOW |
Spragens (Jeffrey G.) | Individual Investor | 0.7837 | 394989 | 299002 | 2023-05-12 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5963 | 300529 | 0 | 2023-03-31 | LOW |
First Manhattan Co. LLC | Investment Advisor | 0.5512 | 277777 | 277777 | 2023-03-31 | LOW |
Reich (Samuel J.) | Individual Investor | 0.4127 | 208001 | 0 | 2023-05-12 | |
Warberg Asset Management LLC | Hedge Fund | 0.3525 | 177659 | -192711 | 2023-03-31 | HIGH |
IFAM Capital | Investment Advisor | 0.2972 | 149774 | 0 | 2023-03-31 | LOW |
Meteora Capital LLC | Hedge Fund | 0.2669 | 134524 | 0 | 2023-03-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2102 | 105959 | 1860 | 2023-03-31 | LOW |
Bridgeway Capital Management, LLC | Investment Advisor | 0.1667 | 84000 | 0 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1612 | 81241 | 0 | 2023-03-31 | LOW |
Hightower Advisors, LLC | Investment Advisor | 0.1458 | 73470 | -2500 | 2023-03-31 | LOW |
Link (David Charles) | Individual Investor | 0.1377 | 69410 | 0 | 2023-05-12 | HIGH |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
SAB Biotherapeutics, Inc. Company profile
Ettevõttest SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc., varem Big Cypress Acquisition Corp., on kliinilise faasi biofarmatseutiline ettevõte. Ettevõte pakub terapeutilist mootorit, mida nimetatakse DiversitAb platvormiks, et toota uue klassi spetsiifiliselt suunatud polüklonaalseid antikehi, ilma et oleks vaja inimdoonoreid. DiversitAb platvorm võimaldab toota polüklonaalseid antikehi ravimeid, mis on mõeldud kaasaegsete terviseprobleemide, sealhulgas COVID-19, hooajalise gripi, 1. tüüpi diabeedi ja vähktõve tekkimise, mutatsiooni ja mitmekesisuse vastu. Tema tootekandidaatide hulka kuuluvad SAB-176, SAB-185, SAB-142 ja SAB-181. Ettevõte töötab välja uue klassi immunoteraapiaid, mis kasutavad ära inimese loomulikku immuunvastust ja mis hõlmavad kõiki ravikategooriaid, sealhulgas nakkushaiguste immuunsüsteemi häireid ja immunonkoloogiat.
Industry: | Biotechnology & Medical Research (NEC) |
2100 East 54Th Street North
Suite 202
SIOUX FALLS
SOUTH DAKOTA 57104
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com